 It is on the World Health Organization's List of Essential Medicines, the safest and most effective medicines needed in a health system.In the United Kingdom, as of 2015, the medication costs the NHS about 2,505.00 GBP per month of treatment.Dasatinib is used to treat people with chronic myeloid leukemia and people with acute lymphoblastic leukemia who are positive for the Philadelphia chromosome.